EVOLENT HEALTH INC - A (EVH) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:EVH - US30050B1017 - Common Stock
3.94 USD
-0.07 (-1.75%)
3.99 USD
+0.05 (+1.27%)
ChartMill assigns a Buy % Consensus number of 85% to EVH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.38. This target is 163.51% above the current price.
EVH was analyzed by 19 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EVH.
In the previous month the buy percentage consensus was at a similar level.
EVH was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-21 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-13 | BMO Capital | Initiate | Outperform |
| 2025-11-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-11-10 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-07 | BTIG | Maintains | Buy -> Buy |
| 2025-09-30 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-24 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-09-09 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-17 | Truist Securities | Maintains | Buy -> Buy |
| 2025-06-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-13 | Needham | Reiterate | Buy -> Buy |
| 2025-05-09 | UBS | Maintains | Buy -> Buy |
| 2025-04-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-10 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-10 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-24 | Citizens Capital Markets | Maintains | Market Outperform -> Market Outperform |
| 2025-02-21 | Needham | Reiterate | Buy -> Buy |
| 2025-02-21 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-02-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-12 | Needham | Reiterate | Buy -> Buy |
| 2025-01-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-24 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-01-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-22 | Truist Securities | Maintains | Buy -> Buy |
| 2025-01-21 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
EVOLENT HEALTH INC - A / EVH FAQ
What is the price target for EVH stock?
19 analysts have analysed EVH and the average price target is 10.38 USD. This implies a price increase of 163.51% is expected in the next year compared to the current price of 3.94.
What is the consensus rating for EVH stock?
The consensus rating for EVOLENT HEALTH INC - A (EVH) is 85.2632 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for EVOLENT HEALTH INC - A stock?
The number of analysts covering EVOLENT HEALTH INC - A (EVH) is 19.